The largest database of trusted experimental protocols

10 protocols using anti ciap1

1

Western Blotting Analysis of Apoptosis Regulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting analysis was performed as previously described [30 (link)]. Anti-cIAP1 was obtained from R&D System (Minneapolis, MN). Anti-Bax and cIAP2 antibodies were obtained from Santa Cruz Biotech (Santa Cruz, CA). Anti-Bak and xIAP antibodies were obtained from Cell Signaling Biotech (Danvers, MA), anti-Bcl-2, and Bcl-xL antibodies were obtained from BD Biosciences (San Diego, CA), and anti-β-actin was obtained from Sigma (St Louis, MO).
+ Open protocol
+ Expand
2

Immunoblotting Analysis of NF-κB Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-cell (30 µg), cytoplasmic (30 µg) and nuclear (10 µg) lysates were resolved by SDS-PAGE and analyzed by immunoblotting. The following antibodies were used: anti-NF-κB2 p52 (C-5) (Santa Cruz Biotechnology, #sc-7386) for detection of p52 and its precursor p100; anti-NIK (Cell Signaling, Danvers, MA, USA, #4994); anti-RelB (C-19) (Santa Cruz Biotechnology, #sc-226); anti-phospho-p100 (Ser866/870) (Cell Signaling, #4810); anti-phospho-IκBα (Ser32/36) (5A5) (Cell Signaling, #5205); anti-IκBα (C-21) (Santa Cruz Biotechnology, #sc-371); anti-phospho-IKKα(Ser180)/IKKβ (Ser181) (Cell Signaling, #2681), anti-IKKα (H-744, Santa Cruz Biotechnology, #sc-7218), anti-IKKα/β (H-470, Santa Cruz Biotechnology, #sc-7607), anti-TRAF2 (C90-481) (BD Biosciences, San Jose, CA, USA, 558890); anti-TRAF3 (H-122) (Santa Cruz Biotechnology, SC-1828); anti-cIAP1 (R&D systems, Minneapolis, MN, USA, AF8181); anti-lamin A/C (4C11) (Cell signaling, #4774); anti-α-tubulin (Sigma-Aldrich, St Louis, MO, USA, T9026). For detection of endogenous NIK protein, cells were treated with 0.1% DMSO or 20 µM of MG132 (PEPTIDE INSTITUTE, Osaka, Japan) for 6 hours and cytoplasmic extracts were subjected to immunoblot analysis.
+ Open protocol
+ Expand
3

Antibodies for Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analysis was performed as described previously [17] (link) using the following antibodies: anti-cIAP1 (R&D Systems, Inc., Wiesbaden-Nordenstadt, Germany), anti-cIAP2 (Epitomics, Burlingam, CA), anti-XIAP from BD Biosciences, anti–phospho-p65 from Cell Signaling (Beverly, MA), anti-phospho-IκBα and anti-IκBα (Cell Signaling), anti-β-actin (Sigma), anti-p65, and anti-p52 from Santa Cruz Biotechnology (Santa Cruz, CA). Donkey anti-mouse IgG, donkey anti-rabbit IgG, or donkey anti-goat IgG labeled with IRDye infrared dyes was used for fluorescence detection at 680 or 800 nm (LI-COR Biotechnology, Bad Homburg, Germany).
+ Open protocol
+ Expand
4

Ceramide Analogs Induced Apoptosis Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting analysis was performed as previously described69 (link). Briefly, tumor cells were cultured in the presence of the indicated ceramide analogs or ceramide analogs plus MegaFasL for 4 h. Cells were collected and lysed in cytosol buffer [10 mM Hepes, pH 7.4, 250 mM Sucrose, 70 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, protease and phosphatase inhibitor cocktails (Calbiochem, Billerica, MA), and 0.01% digitonin] for 10 min. Cytosolic fractions were resolved in 4–20% SDS polyacrylamide gel and analyzed by Western blotting. Anti-cleaved caspase 8 and anti-cIAP1 were obtained from R&D Systems. Anti-cleaved human PARP, anti-xIAP, anti-p38, anti-p-p38, anti-pErk1/2, anti-Erk1/2, anti-pJNK, and anti-JNK antibodies obtained from Cell Signaling. β-actin was obtained from Sigma-Aldrich.
+ Open protocol
+ Expand
5

Antibody Validation in Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
N-acetylcysteine was obtained from Sigma-Aldrich (St. Louis, MO, USA, A9165). The antibodies were obtained as follows: anti-actin (Chemicon, Billerica, MA, USA, 1501); anti-AKT (Cell Signaling, Danvers, MA, USA, 9272); anti-Bad (Santa Cruz, Dallas, TX, USA, sc-7869); anti-Bax (Santa Cruz, sc-493); anti-Bcl-2 (Santa Cruz; sc-509); anti-Bcl-XL (Cell Signaling, 2764); anti-Bim (Cell Signaling, 2933); anti-Caspase 2 (Cell Signaling, 2224); anti-Caspase 3 (Imgenex, San Diego, CA, USA, IMG-144A); anti-cIAP1 (R&D Systems, Minneapolis, MN, USA, AF8181); anti-GAPDH (Santa Cruz, sc-32233); anti-ISCU (Santa Cruz; sc-373694); anti-Mcl-1 (Santa Cruz, sc-819); anti-pAKT (S472/473) (Cell Signaling, 4058); anti-Puma (Cell Signaling, 4976); anti-XIAP (Cell Signaling, 2045).
+ Open protocol
+ Expand
6

Comprehensive Western Blot Analysis of Cell Death Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot was performed as described [21 (link)]. Primary antibodies used were anti-actin (1:2000 MP Biomedicals C4), anti-caspase-8 (1:300 Cell Signaling #9746 and 1:300, Abcam ab32125), anti-caspase-3 (1:1000 Cell Signaling #9662), anti-caspase-7 (1:400 Cell Signaling #12827), anti-RIP1 (1:500 BD Biosciences 610458), anti-XIAP (1:400 BD Biosciences 610762), anti-cIAP1 (1:200 R&D Systems AF8181), anti-p100/p52 (1:500 Cell Signaling #4882) and anti-c-FLIP (1:400 Cell Signaling #5634). Secondary horseradish peroxidase-labeled antibodies were from GE Healthcare and Dako and were used at 1:5000 dilutions. For the chemiluminescent reaction, Supersignal Substrate (Thermo Scientific) was used. Chemiluminescence was detected with a LAS-1000 CCD camera and Image Reader LAS-1000 Pro v2.6 software (Fujifilm, Tokyo, Japan) or an Amersham Imager 600 (GE Healthcare, Chicago, IL, USA).
+ Open protocol
+ Expand
7

Co-immunoprecipitation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti‐EndoG (Proteintech, Rosemont, IL, USA), antiactin (Bethyl, Montgomery, TX, USA), anti‐HA (Covance, Emeryville, CA, USA), anti‐PARP‐1 (Santa Cruz Biotechnology, Inc. Dallas, TX, USA), anti‐His, anti‐GFP, anti‐β‐tubulin, anti‐myc 9E10 (Millipore, Billerica, MA, USA), and anti‐cIAP1 (R&D Systems, Minneapolis, MN, USA) were used for WB or co‐ IP assays.
Co‐IP was performed as follows unless otherwise noted. Cells were lysed in lysis buffer (50 mm Tris pH 8.0, 150 mm NaCl, 1 mm EDTA, 10% glycerol, 1% Triton X‐100, protease inhibitor cocktail). WCLs were mixed with the indicated antibody for 2 h at 4 °C. Protein‐A sepharose beads (Sigma‐Aldrich) were incubated with the immunocomplex for 2 h at 4 °C and then washed three times with IP wash buffer (20 mm Tris pH 8.0, 150 mm NaCl, 1 mm EDTA, 1% Triton X‐100). Samples were subjected to sodium dodecyl‐sulfate polyacrylamide gel electrophoresis and analyzed by WB.
+ Open protocol
+ Expand
8

Western Blot Analysis of Apoptosis Regulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting analysis was performed as previously described [65 (link)]. Anti-cleaved caspase 8 (Cat#: AF705, 0.5μg/ml) and anti-cIAP1 (Cat#: AF8181, 1:500) were obtained from R&D systems. Anti-caspase 3 (Cat#: 9661, 1:1000), anti-caspase 9 (Cat#: 9501, 1:500), anti-PARP (Cat#: 9541, 1:250), anti-xIAP (Cat#: 2042, 1:500), anti-p100/p52 (Cat#: 4882, 1:1000), anti-IκBα (Cat#: 4814, 1:2000), anti-pIκBα (Cat#: 2859, 1:1000) antibodies were obtained from Cell Signaling. Anti-cIAP2 (Cat#: NB110-57030, 1:250) was obtained from Novus. Anti-β-actin (Cat#: A5441, 1:5000) was obtained from Sigma (St Louis, MO).
+ Open protocol
+ Expand
9

Investigating NF-κB Pathway Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human LIGHT, anti-cIAP1, and pan-cIAP antibodies were from R&D Systems. Anti-NIK and -mouse p100/p52 were from Cell Signaling Technology. Anti-human p100/p52 was from Millipore. Anti-IκBα was from Santa Cruz Biotechnology and anti-NEMO was from MBL International. Anti-IKKα was from Imgenex and monoclonal anti-cIAP1 was from Enzo Life Sciences. Horseradish Peroxidase-conjugated secondary antibodies were from Jackson Immuno Research. Agonistic antibody against the LTβR (5G11) was from Abcam. Protein λ-phosphatase was from New England Biosciences. Anti-α-Tubulin and MG132 were from Sigma-Aldrich. Bortezomib was a generous gift from Katherine A. High, M.D. (The Children's Hospital of Philadelphia). Bortezomib was used at a final concentration of 500nM. Cells were treated with 0.05% DMSO as a control. Cycloheximide was from EMD Millipore and used a final concentration of 2.5 μg/mL. As a control, cells were treated with 0.1% ethanol. The active Smac mimetic GT13072 and the inactive Smac mimetic GT13199 were generously provided by TetraLogic Pharmaceuticals (Malvern, PA). Smac mimetics were used at a final concentration of 1uM. Cells were treated with 0.1% DMSO as a control.
+ Open protocol
+ Expand
10

E2F1 and cIAP1 Immunoprecipitation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells (106 per conditions) were transfected with plasmids encoding E2F1 wt or K161/164 R mutant, cIAP1 wt or DP1. Forty-eight hours after transfection, cells were washed with PBS and lysed in IP Lysis buffer (150 mM de NaCl, 50 mM Tris HCl pH 7,4, 20 mM EDTA, 0,5% NP40, 1 mM DTT, 5 mM N-ethylmaleimide (Sigma-Aldrich) and protease inhibitors) for 30 min at 4 °C. Lysate supernatants were precleaned by using 20 μl of Protein A/G+ Agarose beads (Sigma) and incubated (overnight, 4 °C) with rabbit polyclonal anti-E2F1 (C20) antibody (Santa Cruz Biotechnology), mouse IgG1 purified anti-HA.11 (Biolegend), goat polyclonal anti-cIAP1 (R&D Systems) or Igg anti-mouse or anti-rabbit antibody. Beads were then washed in IP lysis buffer and denaturated in Laemmli buffer before immunoblot analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!